ΗΜΕΡΟΜΗΝΙΕΣ
05/11/2025 - 07/11/2025
ΣΥΝΟΛΟ ΕΠΙΣΚΕΨΕΩΝ
1390
Google Calendar ICal Outlook

Videos On Demand

05/11/2025
Ceftolozane/Tazobactam, in the treatment of infections caused by resistant Gram(-) bacteria | K. Akinosoglou
25 Προβολές
Difficult to treat Pseudomonas infections | Y. Carmeli
26 Προβολές
Resistance in Candida and Aspergillus: how to treat? | P. Verweij
25 Προβολές
Bacterial endocarditis in the ICU: how to treat? | J.F. Timsit
24 Προβολές
Two carbapenems for XDR? Why? | M. Samarkos
24 Προβολές
Intrathecal application of antibiotics. Where do we stand? | D. Kofteridis
15 Προβολές
RSVPreF: Optimising RSV disease prevention through vaccination | K. Akinosoglou
25 Προβολές
The Role of Aztreonam/Avibactam in Managing Severe Infections Caused by MBL-Producing Pathogens | E. Douka
27 Προβολές
06/11/2025
How to get your paper accepted | J. Rello
25 Προβολές
Sulbactam-Durlobactam | Y. Carmeli
25 Προβολές
Gepotidacin | N. Sipsas
23 Προβολές
ZolIflodacin | D. R. Giacobbe
22 Προβολές
Opelconazole | O. Cornely
22 Προβολές
Prevention of CRBSIs in all access points. Clinical Evidence and Guidelines | G. Theodorakopoulos
23 Προβολές
Nosocomial Viral Infections in the critically ill | M. Bassetti
26 Προβολές
Host directed therapies and immunomodulation in critically ill patients | E. Giamarellos-Bourboulis
24 Προβολές
Volatilomic / Endocan: new biomarkers for sepsis | D. Annane
24 Προβολές
Biomarkers and Personalized diagnosis in critically ill | E. Giamarellos - Bourboulis
23 Προβολές
Clinical vs autopsy discrepancies in the ICU | A. Menis
31 Προβολές
Data suggesting double treatment in systemic mycosis | P. Verweij
22 Προβολές
Post sepsis / Post ICU syndrome | I. Tatouli
40 Προβολές
Role of lung microdialysis in nebulized antibiotics | A. Torres
24 Προβολές
GREEN ICUs: is possible? | M. Antonelli
23 Προβολές
Difficult to treat gram-positive infections and the role of oritavancin | S. F. Assimakopoulos
26 Προβολές
Real world data for the use of Meropenem - Vaborbactam in CRE infections | K. Pontikis
37 Προβολές
Long COVID | E. Dimopoulou
24 Προβολές
Candidemia immunomodulatory treatment | H. Florou
73 Προβολές
Clarithromycin for CAP | M. Nikolakea
22 Προβολές
EMBRACE the critically ill | K. Leventogiannis
23 Προβολές
07/11/2025
Oteseconazole | M. Gamaletsou
41 Προβολές
Cefiderocol | K. Mantzarlis
27 Προβολές
Delafloxacin | D.R. Giacobbe
25 Προβολές
New inhibitors: taniborbactam, zidebactam, emimetazobactam | D.R. Giacobbe
23 Προβολές
Cefiderocol / xeruborbactam | M. Samarkos
24 Προβολές
Bacteriophages | G. Dimopoulos
16 Προβολές
Maintenance of Skin Integrity and Prevention of Pressure Injuries in critically ill patients | G. Theodorakopoulos
21 Προβολές
Viral Pneumonia in the ICU. Implications beyond the virus | J. Rello
25 Προβολές
RSV infections | M. Mikulska
21 Προβολές
CMV infections in heamatological patients | M. Mikulska
23 Προβολές
Flu vaccination: QIVc vs QIVe vs aTIV | K. Akinosoglou
21 Προβολές
Long-term health implications for people living with HIV | H. Sambatakou
22 Προβολές
Rationale for nebulizing aminoglycosides and polymyxins | J.J. Rouby
21 Προβολές
Techniques of nebulization | K. Pontikis
28 Προβολές
Experimental data supporting the use of nebulized aminoglycosides in VAP | A. Torres
22 Προβολές
Nebulized colistimethate sodium for VAP: which dose and which nebulizer | M. Antonelli
24 Προβολές
Interest of combining nebulized colistimethate and nebulized fosfomycin | G. Dimopoulos
15 Προβολές
Unanswered questions and future research | J.J. Rouby
21 Προβολές
The ENAVAP: the new orientation | J.J. Rouby
27 Προβολές
The COLIPED multicenter RCT | F. Thabet
40 Προβολές
The AMICOL multicenter cluster-randomized Greek study | K. Pontikis
30 Προβολές